Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Current Leases (2019 - 2025)

Tvardi Therapeutics' Current Leases history spans 7 years, with the latest figure at $116000.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 12.62% to $116000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $116000.0, a 12.62% increase, with the full-year FY2025 number at $116000.0, up 12.62% from a year prior.
  • Current Leases hit $116000.0 in Q4 2025 for Tvardi Therapeutics, up from $113000.0 in the prior quarter.
  • Over the last five years, Current Leases for TVRD hit a ceiling of $3.4 million in Q3 2024 and a floor of $103000.0 in Q4 2024.
  • Historically, Current Leases has averaged $1.2 million across 5 years, with a median of $1.5 million in 2021.
  • Biggest five-year swings in Current Leases: skyrocketed 587.53% in 2024 and later crashed 96.69% in 2025.
  • Tracing TVRD's Current Leases over 5 years: stood at $1.8 million in 2021, then rose by 9.29% to $1.9 million in 2022, then plummeted by 74.09% to $497000.0 in 2023, then crashed by 79.28% to $103000.0 in 2024, then increased by 12.62% to $116000.0 in 2025.
  • Business Quant data shows Current Leases for TVRD at $116000.0 in Q4 2025, $113000.0 in Q3 2025, and $109000.0 in Q2 2025.